CLPT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Clearpoint Neuro Inc (CLPT) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company shows some positive growth in financial performance, the lack of significant trading signals, neutral sentiment from hedge funds and insiders, and absence of recent news or catalysts make it prudent to wait for a clearer entry point or stronger signals.
The MACD histogram is positive at 0.169 but contracting, indicating weakening bullish momentum. The RSI is neutral at 53.111, and moving averages are converging, showing no clear trend. Key support and resistance levels suggest a pivot at 13.995, with resistance at 15.03 and support at 12.96. Overall, technical indicators are neutral.
The company's financials for Q3 2025 show positive growth trends: revenue increased by 9.10% YoY, net income improved by 18.44% YoY, EPS rose by 16.67% YoY, and gross margin increased by 5.90%.
The stock has seen a recent price decline of -4.82% in the regular market and -3.56% in pre-market trading. There is no recent news or event-driven catalysts to support a bullish case. Additionally, hedge funds and insiders are neutral, and there is no recent trading activity from Congress.
In Q3 2025, Clearpoint Neuro Inc reported revenue growth of 9.10% YoY to $8.86 million. Net income improved to -$5.89 million, up 18.44% YoY, while EPS increased by 16.67% YoY to -0.21. Gross margin rose to 63.2%, up 5.90% YoY. Despite improvements, the company remains unprofitable.
No recent updates on analyst ratings or price target changes are available.
